Astrana Health [ASTH] vs Pediatrix Medical [MD] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Astrana Health Inc. wins in 5 metrics, Pediatrix Medical Group, Inc. wins in 15 metrics, with 0 ties. Pediatrix Medical Group, Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Astrana Health Inc. Pediatrix Medical Group, Inc. Better
P/E Ratio (TTM) 73.30 11.88 Pediatrix Medical Group, Inc.
Price-to-Book Ratio 2.12 2.16 Astrana Health Inc.
Debt-to-Equity Ratio 193.10 73.29 Pediatrix Medical Group, Inc.
PEG Ratio -0.41 9.90 Pediatrix Medical Group, Inc.
EV/EBITDA 14.57 7.92 Pediatrix Medical Group, Inc.
Profit Margin (TTM) 0.71% 8.64% Pediatrix Medical Group, Inc.
Operating Margin (TTM) 1.85% 11.07% Pediatrix Medical Group, Inc.
EBITDA Margin (TTM) 1.85% 11.07% Pediatrix Medical Group, Inc.
Return on Equity 4.49% 20.28% Pediatrix Medical Group, Inc.
Return on Assets (TTM) 3.43% 6.57% Pediatrix Medical Group, Inc.
Free Cash Flow (TTM) $104.49M $252.63M Pediatrix Medical Group, Inc.
1-Year Return 49.98% 73.57% Pediatrix Medical Group, Inc.
Price-to-Sales Ratio (TTM) 0.59 1.00 Astrana Health Inc.
Enterprise Value $2.10B $2.00B Astrana Health Inc.
EV/Revenue Ratio 0.66 1.05 Astrana Health Inc.
Gross Profit Margin (TTM) 10.00% 25.51% Pediatrix Medical Group, Inc.
Revenue per Share (TTM) $65 $23 Astrana Health Inc.
Earnings per Share (Diluted) $0.46 $1.94 Pediatrix Medical Group, Inc.
Beta (Stock Volatility) 0.77 0.72 Pediatrix Medical Group, Inc.
Short % of Float 8.35% 6.00% Pediatrix Medical Group, Inc.

Astrana Health Inc. vs Pediatrix Medical Group, Inc. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Astrana Health Inc.-0.62%-0.03%0.31%56.02%72.11%52.18%
Pediatrix Medical Group, Inc.0.29%8.46%8.36%25.04%7.40%14.47%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Astrana Health Inc.49.98%24.10%-27.77%642.69%657.25%657.25%
Pediatrix Medical Group, Inc.73.57%75.20%-20.69%-64.71%-31.34%9.12%

Performance & Financial Health Analysis: Astrana Health Inc. vs Pediatrix Medical Group, Inc.

MetricASTHMD
Market Information
Market Cap i$1.88B$1.91B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i497,178510,889
90 Day Avg. Volume i435,283755,756
Last Close$38.38$24.37
52 Week Range$18.08 - $40.13$11.84 - $24.99
% from 52W High-4.36%-2.48%
All-Time High$133.23 (Nov 15, 2021)$86.09 (Aug 17, 2015)
% from All-Time High-71.19%-71.69%
Growth Metrics
Quarterly Revenue Growth0.43%-0.02%
Quarterly Earnings Growth0.43%0.11%
Financial Health
Profit Margin (TTM) i0.01%0.09%
Operating Margin (TTM) i0.02%0.11%
Return on Equity (TTM) i0.04%0.20%
Debt to Equity (MRQ) i193.1073.29
Cash & Liquidity
Book Value per Share (MRQ)$15.94$10.68
Cash per Share (MRQ)$8.68$6.16
Operating Cash Flow (TTM) i$114.60M$271.09M
Levered Free Cash Flow (TTM) i$227.95M$190.33M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Astrana Health Inc. vs Pediatrix Medical Group, Inc.

MetricASTH (Apr 26, 2026)MD (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i73.3011.88
Forward P/E i10.509.90
PEG Ratio i-0.419.90
Price to Sales (TTM) i0.591.00
Price to Book (MRQ) i2.122.16
Market Capitalization
Market Capitalization i$1.88B$1.91B
Enterprise Value i$2.10B$2.00B
Enterprise Value Metrics
Enterprise to Revenue i0.661.05
Enterprise to EBITDA i14.577.92
Risk & Other Metrics
Beta i0.770.72
Book Value per Share (MRQ) i$15.94$10.68

Financial Statements Comparison: Astrana Health Inc. vs Pediatrix Medical Group, Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricASTH (2025)MD (2025)
Revenue/Sales i3.18B1.91B
Cost of Goods Sold i2.84B1.42B
COGS % of Revenue i89.3%74.2%
Gross Profit i341.53M493.70M
Gross Margin i10.7%25.8%
Research & Development iN/AN/A
Operating Income (EBIT) i78.53M231.09M
Operating Margin i2.5%12.1%
EBITDA i135.35M256.55M
EBITDA Margin i4.3%13.4%
Pre-Tax Income i39.61M216.43M
Pre-Tax Income % of Revenue i1.2%11.3%
Income Tax i15.53M51.04M
Income Tax % of Revenue i0.5%2.7%
Net Income (Profit) i24.08M165.39M
Profit Margin i0.8%8.6%

Balance Sheet & Liquidity Metrics

MetricASTH (2025)MD (2025)
Cash & Equivalents i429.47M375.24M
Total Current Assets i863.31M763.51M
Total Current Assets % of Revenue i27.1%39.9%
Total Current Liabilities i615.27M458.91M
Total Current Liabilities % of Revenue i19.3%24.0%
Long-Term Debt i1.02B596.22M
Long-Term Debt % of Revenue i32.1%31.2%
Total Shareholders Equity i558.33M865.85M
Retained Earnings i308.38M-83.15M
Retained Earnings % of Revenue i9.7%-4.3%
Property, Plant & Equipment i35.74M195.53M

Cash Flow Statement Comparison

MetricASTH (2025)MD (2025)
Operating Cash Flow i109.88M270.23M
Operating Cash Flow % of Revenue i3.5%14.1%
Capital Expenditures i-10.11M-18.46M
Free Cash Flow i104.49M252.63M
FCF Margin i3.3%13.2%
Debt Repayment i-495.29M-20.75M
Common Stock Repurchase i-15.43M-86.68M

Short Interest & Institutional Ownership Analysis

MetricASTHMD
Shares Short i2.68M3.53M
Short Ratio i6.863.77
Short % of Float i8.35%6.00%
Shares Outstanding i48.89M82.98M
Float Shares i44.36M79.95M
% Held by Insiders i20.32%2.31%
% Held by Institutions i52.52%106.63%
% Held by Public i27.16%-8.94%

Dividend Analysis & Yield Comparison: Astrana Health Inc. vs Pediatrix Medical Group, Inc.

MetricASTHMD
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A